SPDR S&P Biotech ETF $XBI Shares Purchased by 5th Street Advisors LLC

5th Street Advisors LLC raised its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 5.1% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 18,072 shares of the exchange traded fund’s stock after buying an additional 882 shares during the period. SPDR S&P Biotech ETF makes up 0.7% of 5th Street Advisors LLC’s portfolio, making the stock its 26th biggest position. 5th Street Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $1,499,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also recently bought and sold shares of the company. RFG Advisory LLC bought a new position in shares of SPDR S&P Biotech ETF during the 2nd quarter valued at about $208,000. Fulcrum Capital LLC boosted its position in shares of SPDR S&P Biotech ETF by 6.0% during the 2nd quarter. Fulcrum Capital LLC now owns 54,960 shares of the exchange traded fund’s stock valued at $4,558,000 after purchasing an additional 3,122 shares in the last quarter. Robertson Stephens Wealth Management LLC boosted its position in shares of SPDR S&P Biotech ETF by 36.4% during the 2nd quarter. Robertson Stephens Wealth Management LLC now owns 4,721 shares of the exchange traded fund’s stock valued at $392,000 after purchasing an additional 1,261 shares in the last quarter. IFP Advisors Inc boosted its position in shares of SPDR S&P Biotech ETF by 22.8% during the 2nd quarter. IFP Advisors Inc now owns 3,909 shares of the exchange traded fund’s stock valued at $324,000 after purchasing an additional 727 shares in the last quarter. Finally, Meitav Investment House Ltd. boosted its position in shares of SPDR S&P Biotech ETF by 2,199.6% during the 2nd quarter. Meitav Investment House Ltd. now owns 400,454 shares of the exchange traded fund’s stock valued at $33,229,000 after purchasing an additional 383,040 shares in the last quarter.

SPDR S&P Biotech ETF Trading Up 3.1%

NYSEARCA:XBI opened at $108.37 on Thursday. SPDR S&P Biotech ETF has a twelve month low of $66.66 and a twelve month high of $108.62. The company has a 50-day moving average of $95.16 and a 200-day moving average of $86.21. The firm has a market cap of $6.45 billion, a price-to-earnings ratio of 11.47 and a beta of 0.97.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.